Welcome Dennis Van Liew!

📢 We are excited to welcome Dennis Van Liew, “Denny”, to ETL as a Senior Advisor to our leadership team!

🌍 Dennis brings decades of experience in pharmacovigilance, regulatory operations, and life sciences strategy. His background includes senior leadership roles at Pfizer, Bioclinica (now Qinesca), Kinapse (now Syneos Health), and Red Nucleus, where he led large-scale corporate transformation initiatives integrating regulatory and safety functions across top global pharma.

⭐ As founder of The Pareto Group, Dennis has advised precision medicine and healthcare ventures on operational scaling, governance, and strategic partnerships. His advisory expertise will strengthen ETL’s positioning as a trusted partner in global pharmacovigilance services, regulatory affairs, and risk management.

💡 Dennis is also a board member of Antares Genomics and Treasurer of the International Society of Pharmacovigilance (ISoP Online) North America Chapter.  He is also an emeritus Board Member of the Personalised Medicine Coalition. 

✨ We’re thrilled to have his leadership and insight as we continue expanding ETL’s impact in drug safety and personalised healthcare.

🎉Welcome aboard, Denny!